[1]
Ergür, F. Öztürk, Yıldız, M., Şener, M.U., Kavurgacı, S. and Ozturk, A. 2022. Adverse effects associated with favipiravir in patients with COVID-19 pneumonia: a retrospective study. São Paulo Medical Journal. 140, 3 (May 2022), 372–377.